JRSIS Health Care Corporation
JRSS · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $1,325 | $3,462 | $89 | $44,391 |
| % Growth | -61.7% | 3,782.6% | -99.8% | – |
| Cost of Goods Sold | $1,051 | $2,979 | $14,712 | $20,198 |
| Gross Profit | $274 | $483 | -$14,623 | $24,193 |
| % Margin | 20.7% | 14% | -16,399.6% | 54.5% |
| R&D Expenses | $50 | $189 | $283 | $0 |
| G&A Expenses | $387 | $336 | $283 | $15,360 |
| SG&A Expenses | $711 | $482 | $428 | $15,395 |
| Sales & Mktg Exp. | $324 | $146 | $145 | $36 |
| Other Operating Expenses | $0 | $0 | -$2 | $267 |
| Operating Expenses | $760 | $672 | $400 | $18,709 |
| Operating Income | -$486 | -$189 | -$326 | $4,103 |
| % Margin | -36.7% | -5.4% | -365.5% | 9.2% |
| Other Income/Exp. Net | -$21 | $103 | $12 | $0 |
| Pre-Tax Income | -$507 | -$86 | -$328 | $4,370 |
| Tax Expense | $3 | $9 | $33,067,781 | $1,181 |
| Net Income | -$510 | -$81 | -$33,721 | $2,232 |
| % Margin | -38.5% | -2.3% | -37,818.6% | 5% |
| EPS | -0.006 | -0.001 | -0.55 | 0.12 |
| % Growth | -500% | 99.8% | -558.3% | – |
| EPS Diluted | -0.006 | -0.001 | -0.55 | 0.12 |
| Weighted Avg Shares Out | 84,599 | 77,253 | 61,334 | 18,452 |
| Weighted Avg Shares Out Dil | 84,599 | 77,253 | 61,334 | 18,662 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $3 | $0 | $0 |
| Interest Expense | $21 | $56 | $65 | $1,382 |
| Depreciation & Amortization | $36 | $58 | $54 | $3,314 |
| EBITDA | -$450 | $29 | -$555 | $4,103 |
| % Margin | -33.9% | 0.8% | -622.2% | 9.2% |